ZGC 2021 Lunar New Year Event

ZGC 2021 Lunar New Year Event “Post-COVID Transformation” Conversations with Investors

As 2021 Lunar New Year is approaching, we’d like to invite you to join us online for “ZGC Lunar New Year Event”.

Every year during Spring Festival we have ZGC’s community members and partners gathered together to celebrate the special occasion and share their achievements over the year. Responding to the COVID-19 pandemic, this year’s event will be held online featuring discussions and exchanges within ZGC’s community on recent hot topics of venture capital and healthcare innovation.

During the online session, we will also arrange the Spring Festival lottery draw between panels and pitches. Wish all the guests lucky and auspicious in the coming year!

Here is the Agenda

Event Name: 2021 ZGC Spring Festival Event

Event Theme: “Post COVID Transformation”

Event Time: Feb. 10th, 3:00pm-5:30pm PST

Location: Zoom Online Meeting (To be Announced)

3:00-3:05 Welcome & Introduction

3:05-3:15 CEO’s Opening Remarks

3:15-3:20 Spring Festival Celebration Activity/Lucky Draw

3:20-4:00 “Post-COVID Era” Opportunities for Healthcare Industry (Panel)

4:00-4:05 Spring Festival Fun Activity/Lucky Draw

4:05-4: 50 The Future of Venture Capital (Panel)

4:50-4:55 Spring Festival Fun Activity/Lucky Draw

4:55-5:20 ZGC Featured Startup Pitches

5:20-5:30 Event Closing

CONFIRMED SPEAKERS FOR HEALTHCARE PANEL

Dr. Debbie Lin | Executive Director, Boehringer Ingelheim Venture Fund

https://www.linkedin.com/in/debbie-w-lin-9209083/

Dr. Debbie Lin is Executive Director at Boehringer Ingelheim Venture Fund in the US and started and leads the Fund’s North American investment efforts in Digital Healthcare. She led the investments for and has Board Directorship roles at Wellth Inc. (New York, NY) and Bodyport Inc. (San Francisco, CA). She joined Boehringer Ingelheim Pharmaceuticals in 2008. Within Boehringer Ingelheim Pharma, she worked across various regions and divisions in both the USA and at the Corporate Headquarters in Germany.

Dr. Orrin Ailloni-Charas | CEO & Managing Partner, Global Health Impact Fund(GHIF)

https://www.linkedin.com/in/orrin-ailloni-charas-md-mba-2975a/

Dr. Ailloni-Charas is the CEO and Managing Partner of the Global Health Impact Fund(GHIF), a venture fund focused on investing in early stage healthcare innovation. The GHIN is physician-led and physician-driven and leverages the expertise of large networks of physicians and domain experts with its proprietary, data science platform. The insights and experiences of the physician leaders, filter through the analytical engine provide the basis for improved investing outcomes by allowing for better understanding of the clinical and business challenges early stage healthcare startups encounter.

Dr. Ella Li | CEO, ZGC Capital & Partner, ZGC U.S. Fund

https://www.linkedin.com/in/ellal/

Dr. Ella Li the CEO of ZGC Capital and the partner of ZGC U.S. Fund, leading ZGC’s team in investment and incubator operation. She established and managed several VC and fund of fund, including one with portfolio funds including KPCB, Menlo, Andreessen Horowitz, Accel and Foundation Capital. Dr. Li has 15+ years of experience in pharmaceutical and biotechnology sectors and has rich investment experiences in therapeutic investment opportunities. She has also rich experiences in digital health, AI and IOT sectors, and serves as board advisor, consultant and mentor for many global accelerators, incubators and VCs. Dr. Ella Li earned her B.S. and M.S. degrees from Peking University, Ph.D. from the University of Texas Health Science Center, and finished her postdoctoral fellowship in Harvard Medical School. She has extensive publications in prestigious journals with 10+ impact factors, including Nature Communication, Cell Metabolism, JCI, PNAS, Diabetes, etc.

Marisa Alma McGinnis | Managing Director, Golden Seeds Silicon Valley, LP Blumberg Fund III, WABA

https://www.linkedin.com/in/marisa-alma-mcginnis-12a632123/

Marisa McGinnis is the Managing Director of Golden Seeds Silicon Valley. Marisa has invested in about 30 start-ups, and the last company she exited was Airbnb. She is currently also an investor in RenovoRx. Marisa earned her B.S. degree in Microbiology and is also a lawyer and real estate agent.

CONFIRMED SPEAKERS FOR VC PANEL

Chon Tang | Managing Partner, Berkeley SkyDeck Fund

https://www.linkedin.com/in/chontang/

Chon Tang is a founder, a computer scientist, and an investor. He is the founding partner of quant hedge fund firm Junzi Capital Engineering, and successful angel investor (36+ deals, 2 IPOs) with a love for all things entrepreneurial. He has now proudly launched the Berkeley SkyDeck Fund in support of UC Berkeley's premier accelerator, and looks to help build Berkeley into a global nexus for entrepreneurship. UC Berkeley BS EECS '98, MIT SM EECS '00.

Jordan Wahbeh | Managing Partner, SV Venture Group

https://www.linkedin.com/in/jordanwahbeh/

Jordan partners with startups and investors to grow, scale, fundraise and achieve their objectives through operations, fundraising, business development, product development, and team leadership. As an experienced leader and advisor, he assists or leads in business operations and development, market growth, org transformation, and customer management. As SV Venture group Managing Partner, VP at Scorpion Capital, and X-MP at Bay Angels’, Jordan has a strong network of resources and SMEs along with a varied portfolio of startups companies. His engagements include VCs, Angels groups, Accelerators, and Corp VC in Silicon Valley, across USA, Korea, Dubai, Brazil, MENA region, and EC.

Dr. Peter Hsieh | General Partner, Acorn Pacific Ventures

https://www.linkedin.com/in/peter-hsieh-9165a/

Dr. Peter Hsieh, General Partner of Acorn Pacific Ventures, has been a venture capitalist for over 2 decades. He is one of the few venture capitalists that has about 10 years of direct venture capital experience in Silicon Valley, and another 10 years of the same in Greater China. Ventures sponsored by Peter have created values of over USD$8B.Before moving back from Taipei to Silicon Valley in 2015, Peter served as Chief Strategy Officer of Coretronic Corporation, President of Coretronic Venture Capital, and President of Optoma Corporation. Peter has a PhD in Ultrasound and Optics from Stanford, and a BS ME from National Taiwan University.

Gopi Rangan | Founding Partner, Sure Ventures

https://www.linkedin.com/in/gopirangan/

Gopi Rangan is the founding partner at Sure Ventures, a Silicon Valley based venture capital firm investing in early-stage startups. He invests with a mission to enable peace of mind. He is also the host of The Sure Shot Entrepreneur podcast and teaches entrepreneurship courses at INSEAD.

-----------------------------------------------------------------------

【ZGC迎新年活动】“后疫情时代”2021年创业创投新风口

2021年春节将至，中关村北美（ZGC）邀您参加『春节线上迎新年活动』，年会将以“后疫情时代” 为主题，就近期科技创业创投领域热点话题与中关村北美社区及合作伙伴展开讨论和交流，并共同庆祝中国春节！

本次年会将汇集硅谷周边知名VC投资人，医疗大健康领域专家和创新创业者一起讨论2021年科技创业创投新风口，包含三大主题板块：2021年几大创投行业的风向变动，后疫情时代医疗健康投资的新机遇，以及创业公司路演分享，以促进中关村北美社区的资讯共享及深入交流。届时我们还在各主题之间穿插安排了春节抽奖环节，也表达了对各位嘉宾来年幸运吉祥的祝福之意。

本次年会的嘉宾主要有：

• 硅谷周边基金合伙人
• 医疗健康领域的专家和投资人
• 中关村北美的合作伙伴及入驻企业

年会将于美西时间 2月10日下午3:00-5:35于zoom线上举行，活动议程暂定如下：

活动名称: 2021中关村北美迎新年活动

活动主题: “后疫情时代”创业创投新风口

活动时间: 美西时间2月10日下午3:00-5:35

活动地点: Zoom Online Meeting (TBA)

3:00-3:10pm 活动正式开始，主持人开场

3:10-3:20pm 中关村北美CEO春节祝贺致辞

3:20-3:30pm “贺新春” 趣味抽奖环节

3:30-4:10pm 投资人圆桌谈话：“后疫情时代” 医疗大健康的新机遇

4:10-4:15pm 贺新春” 趣味抽奖环节

4:15-5:00pm 投资人圆桌谈话：2021年创投行业新风向

5:00-5:05pm 贺新春” 趣味抽奖环节

5:05-5:30pm 中关村北美合作伙伴创业公司路演

5:30-5:35pm 活动结束